Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dynatrace Inc. Common Stock (DT) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Dynatrace Inc. Common StockTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Dynatrace Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Dynatrace Inc. Common Stock trades at $63.48 (market cap $17.66B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B). The key difference: Dynatrace Inc. Common Stock is far larger — about 2.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is more actively traded (14,805,993 versus 8,779,681). Which is the better fit depends on your goals — on Pluang, investors hold Dynatrace Inc. Common Stock for 1 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

DTIOVA
Market Cap
$17.66B$6.04B
Volume
8,779,68114,805,993
Sector
TechnologyHealth
52-Week High
$61.12$14.82
52-Week Low
$32.36$1.81
Typical Hold Time
1 Days0 Days
Enterprise Value
$16.71B$5.97B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DT

No sentiment data available yet.

IOVA
51% Buy49% Sell
Avg holding period · 0 Days

About Dynatrace Inc. Common Stock

Dynatrace provides an observability, security, and automation platform for cloud and IT environments. Its platform integrates data such as logs, metrics, and traces to help organizations monitor digital systems.

Read more on DT →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →